Target intelligence / Profile preview

IQ domain-containing protein M (IQCM)

Target
IQCM
Molecular classification
Other (specifically, plant-specific calmodulin-binding protein)
01

Overview

IQ domain-containing protein M (IQCM) is part of the plant IQM gene family, which encodes proteins with a single IQ motif—a short alpha-helical consensus sequence enabling calcium-independent binding to calmodulin[2]. In plants like soybean and Arabidopsis, IQCM proteins are typically nuclear (occasionally cytoplasmic or chloroplastic) and may regulate cellular events through modulating calmodulin-dependent processes, but are not widely studied outside plant biology[2]. There is no evidence that IQCM acts as a receptor, enzyme, transporter, transcription factor, or other conventional drug target in humans[2]. The “IQ motif” is broadly distributed in many proteins, mainly contributing to calmodulin signaling and cytoskeletal regulation, but the IQCM molecule itself is defined narrowly and without disease or therapeutic implications in current biomedical literature[2][1]. If targeting human or disease-relevant IQ motif proteins, be aware that “IQ motif containing M” may be easily confused with other proteins (e.g., IQGAPs, IQCH), none of which map to IQCM. This entry should be flagged as inaccurate when seeking targets for drug discovery or human therapeutics.

Other names
IQ motif containing MIQCMIQ domain-containing protein MIQM (used generically for the plant IQM family)
02

Mechanism of action

Not applicable; no drug mechanism described for this protein.

03

Biological functions

Calmodulin binding (calcium-independent)Subcellular localization (mainly nuclear; occasionally cytoplasmic or chloroplastic, family-dependent)Regulation of plant cellular processes (diverse, context-specific)
04

Disease associations

Other (no evidence for involvement in human disease or plant disease associations, according to available sources)Not associated with cancer, inflammation, neurodegenerative disease, or infection in humans.
05

Safety considerations

None reported; not an established or investigated therapeutic target
06

Interacting drugs

None reported; no known drugs interact with IQCM or modulate its function
07

Biomarkers

None reported for patient selection or therapeutic efficacy.

Beyond the preview

Go deeper on IQ domain-containing protein M (IQCM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQ domain-containing protein M (IQCM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call